ABBV - AbbVie Inc.
170.3
-0.090 -0.053%
Share volume: 5,473,626
Last Updated: Fri 24 Jan 2025 10:00:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.44%
PREVIOUS CLOSE
CHG
CHG%
$170.39
-0.37
0.00%
Summary score
54%
Profitability
33%
Dept financing
32%
Liquidity
11%
Performance
92%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Sep-2020 - 30-Sep-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
16.27%
Return on assets
2.36%
Return on sales
28.88%
Return on invested capital
2.59%
Total debt ratio
91.15%
Debt ratio change over timeo
100.91%
Current Ratio
0.88%
Quick Ratio
0.77%
Cash Position Ratio
0.3%
Short-term ratios 30-Sep-2023 - 30-Sep-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
1.74%
Return on sales
25.62%
Return on invested capital
0%
Total debt ratio
95.21%
Debt ratio change over timeo
0%
Current Ratio
0.8%
Quick Ratio
0.69%
Cash Position Ratio
0.31%
Last quarter ratios 30-Sep-2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
1.87%
Return on sales
26.49%
Return on invested capital
0%
Total debt ratio
95.79%
Debt ratio change over time
0%
Current Ratio
0.65%
Quick Ratio
0.54%
Cash Position Ratio
0.17%
Performance ratios (change over 4 years) 30-Sep-2020 - 30-Sep-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
781.7%
Return on assets
218.93%
Return on sales
3322.98%
Return on invested capital
33.98%
Total debt ratio
10090.88%
Debt ratio change over time
100.91%
Current Ratio
96.28%
Quick Ratio
83.68%
Cash Position Ratio
33.96%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ABBV | AMGN | VRTX | REGN |
|---|---|---|---|---|
| Return on equity | 16.27% | 18.34% | 4.17% | 7.05% |
| Return on assets | 2.36% | 3.17% | 5.68% | 5.37% |
| Return on sales | 28.88% | 30.73% | 42.61% | 39.73% |
| Return on invested capital | 2.59% | 5.33% | 28.42% | 18.5% |
| Profitability | 52% | 62% | 81% | 73% |
| Total debt ratio | 91.15% | 91.7% | 24.48% | 24.82% |
| Debt ratio change over time | 100.91% | 17.73% | -0% | 1.22% |
| Dept financing | 50% | 29% | 7% | 7% |
| Current Ratio | 0.8% | 1.33% | 3.12% | 5.42% |
| Quick Ratio | 0.69% | 0.94% | 2.88% | 4.63% |
| Cash Position Ratio | 0.31% | 0.46% | 2.2% | 2.36% |
| Liquididy | 12% | 25% | 72% | 67% |
| Short-term ratios | ABBV | AMGN | VRTX | REGN |
|---|---|---|---|---|
| Return on equity | 0% | 0% | -4.29% | 4.07% |
| Return on assets | 1.74% | 2.28% | 4.72% | 3.09% |
| Return on sales | 25.62% | 20.05% | 39.7% | 29.18% |
| Return on invested capital | 0% | 0% | -3.9% | 9.35% |
| Profitability | 25% | 25% | 50% | 85% |
| Total debt ratio | 95.21% | 93.27% | 25.36% | 21.62% |
| Debt ratio change over time | 0% | 0% | -0.58% | 1.38% |
| Dept financing | 25% | 24% | 7% | 31% |
| Current Ratio | 0.8% | 1.33% | 3.12% | 5.42% |
| Quick Ratio | 0.69% | 0.94% | 2.88% | 4.63% |
| Cash Position Ratio | 0.31% | 0.46% | 2.2% | 2.36% |
| Liquididy | 11% | 16% | 53% | 75% |